Modifying Progression – From Molecules to TrialsREGISTER NOW
Grand Challenges in Parkinson’s Disease brings together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest in Parkinson’s disease translational research. The 2022 symposium, Modifying Progression — From Molecules to Trials, will highlight recent advances that may fuel development of therapies to slow or stop disease progression — something not possible with current treatments. Speakers will highlight both the underlying molecular science of Parkinson’s and the outcomes of new clinical trials. They also will explore the role of mitochondrial function, neuroinflammation, alpha-synuclein and lysosomes in Parkinson’s, with a focus on how these factors may be targeted with disease-modifying treatments. Lastly, they will spotlight new insights into GLP-1 agonists and c-Abl inhibition as potential therapeutic avenues.
Van Andel Institute and Cure Parkinson’s are thrilled to once again host Rallying to the Challenge, a meeting designed for and by people with Parkinson’s, advocates and care partners that delves into how the Parkinson’s community can impact and accelerate research.
For questions or to be added to our mailing list, please contact Kim Cousineau via email here.